Quarterly Updates20 Aug 2026, 05:41 pm
JSLL Q1 FY27 Revenue Up 29% to ₹224.4 Cr on Private-Pay IPD Growth
AI Summary
Jeena Sikho Lifecare Limited (JSLL) reported a 29% year-on-year revenue growth to ₹224.4 crore for the quarter ended June 30, 2026 (Q1 FY27). The growth was primarily driven by private-pay Panchakarma hospitalisation, at-centre medicine sales, and the digital/e-commerce medicine channel. The company is strategically shifting towards higher-quality earnings by focusing on private-pay IPD, which saw a 26% revenue increase and 33% admission growth. This shift comes as revenue from government-panel IPD declined significantly. JSLL aims to optimize centre economics and patient outcomes for sustainable, profitable growth.
Key Highlights
- Q1 FY27 revenue surged 29% YoY to ₹224.4 crore.
- Private-pay IPD revenue grew 26% with 33% higher admissions.
- E-commerce medicine channel saw a 1.9x revenue increase.
- Government-panel IPD revenue declined by 67%.
- Company focuses on higher-quality earnings via private-pay services.
Price Impact
More from JSLL